| Primary |
| Product Used For Unknown Indication |
19.7% |
| Multiple Myeloma |
19.3% |
| Acute Lymphocytic Leukaemia |
11.9% |
| Arthralgia |
4.8% |
| Plasma Cell Myeloma |
4.8% |
| Drug Use For Unknown Indication |
3.9% |
| Chronic Lymphocytic Leukaemia |
3.7% |
| General Anaesthesia |
3.7% |
| Premedication |
3.0% |
| Brain Oedema |
2.8% |
| Vomiting |
2.8% |
| Drug Withdrawal Syndrome |
2.6% |
| Prophylaxis |
2.6% |
| Withdrawal Syndrome |
2.6% |
| Addison's Disease |
2.4% |
| Dermatitis Contact |
1.9% |
| Nausea |
1.9% |
| Plantar Fasciitis |
1.9% |
| Prophylaxis Of Nausea And Vomiting |
1.9% |
| Brain Neoplasm |
1.7% |
|
| Keratopathy |
27.1% |
| Tumour Lysis Syndrome |
5.2% |
| Urticaria |
5.2% |
| Chest Pain |
4.2% |
| Injection Site Pain |
4.2% |
| Medication Error |
4.2% |
| Neutropenia |
4.2% |
| Off Label Use |
4.2% |
| Osteonecrosis |
4.2% |
| Pain |
4.2% |
| Progressive Multifocal Leukoencephalopathy |
4.2% |
| Tympanic Membrane Perforation |
4.2% |
| Dizziness |
3.1% |
| Drug Hypersensitivity |
3.1% |
| Drug Ineffective |
3.1% |
| Drug-induced Liver Injury |
3.1% |
| Encephalitis Herpes |
3.1% |
| Erythema |
3.1% |
| Hyperglycaemia |
3.1% |
| Hypersensitivity |
3.1% |
|
| Secondary |
| Multiple Myeloma |
16.5% |
| Prophylaxis |
14.0% |
| Product Used For Unknown Indication |
9.4% |
| Acute Lymphocytic Leukaemia |
8.7% |
| Drug Use For Unknown Indication |
7.8% |
| Ill-defined Disorder |
5.1% |
| Burkitt's Lymphoma |
3.7% |
| Plasma Cell Myeloma |
3.6% |
| Prophylaxis Of Nausea And Vomiting |
3.6% |
| Burkitt's Leukaemia |
3.5% |
| Refractory Cancer |
3.5% |
| Hypertension |
3.1% |
| Rheumatoid Arthritis |
2.8% |
| Chemotherapy |
2.6% |
| Premedication |
2.3% |
| Vomiting |
2.1% |
| Lymphocytic Leukaemia |
2.0% |
| B Precursor Type Acute Leukaemia |
2.0% |
| Nausea |
1.9% |
| Constipation |
1.7% |
|
| Hyperglycaemia |
9.2% |
| Osteonecrosis |
8.5% |
| Haemoglobin Decreased |
7.8% |
| Posterior Reversible Encephalopathy Syndrome |
6.5% |
| Hypogammaglobulinaemia |
5.2% |
| Sinus Arrhythmia |
5.2% |
| Tumour Lysis Syndrome |
5.2% |
| Cerebral Infarction |
4.6% |
| Gastric Ulcer |
4.6% |
| Mucosal Inflammation |
4.6% |
| Paronychia |
4.6% |
| Rash |
4.6% |
| Vomiting |
4.6% |
| Liver Function Test Abnormal |
3.9% |
| Neuropathy Peripheral |
3.9% |
| Pyrexia |
3.9% |
| Chest Pain |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Nausea |
3.3% |
| Sepsis |
3.3% |
|
| Concomitant |
| Prophylaxis |
16.4% |
| Product Used For Unknown Indication |
14.2% |
| Premedication |
9.5% |
| Drug Use For Unknown Indication |
9.4% |
| Colon Cancer |
6.9% |
| Multiple Myeloma |
6.6% |
| Breast Cancer |
4.6% |
| Prophylaxis Of Nausea And Vomiting |
4.5% |
| Rectal Cancer |
4.2% |
| Colorectal Cancer |
3.6% |
| Constipation |
3.1% |
| Hypertension |
3.0% |
| Colon Cancer Metastatic |
2.2% |
| Pain |
2.2% |
| Chemotherapy |
2.2% |
| Nausea |
1.7% |
| Non-small Cell Lung Cancer |
1.6% |
| Cancer Pain |
1.5% |
| Adenocarcinoma Pancreas |
1.3% |
| Hiv Infection |
1.3% |
|
| White Blood Cell Count Decreased |
12.1% |
| Interstitial Lung Disease |
10.3% |
| Vomiting |
6.9% |
| Pyrexia |
6.2% |
| Nausea |
5.4% |
| Stomatitis |
5.4% |
| Thrombocytopenia |
5.2% |
| Sepsis |
4.9% |
| Pancytopenia |
4.8% |
| Leukopenia |
4.3% |
| Pneumonia |
4.1% |
| Constipation |
3.8% |
| Neutrophil Count Decreased |
3.8% |
| Platelet Count Decreased |
3.6% |
| Neutropenia |
3.4% |
| Peritonitis |
3.4% |
| Anaemia |
3.1% |
| Intestinal Obstruction |
3.1% |
| Rash |
3.1% |
| Death |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
37.5% |
| Convulsion Prophylaxis |
12.5% |
| Bone Pain |
6.3% |
| Cancer Pain |
6.3% |
| Constipation |
6.3% |
| Hyperlipidaemia |
6.3% |
| Neuralgia |
6.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.3% |
| Spinal Cord Compression |
6.3% |
| Supplementation Therapy |
6.3% |
|
| Convulsion |
25.0% |
| Nausea |
25.0% |
| Thrombocytopenia |
25.0% |
| Urosepsis |
25.0% |
|
